01-12 UBS Rejects Proposed Swiss Banking Rules MT
01-12 Novartis eyes more bolt-on acquisitions, CEO says RE
01-12 Swiss Life Places CHF225 Million Hybrid Bond Due 2042 MT
01-12 Swiss Market Index Begins Week Flat; UBS, Novartis Edge Lower MT
01-12 Swiss Life successfully places a hybrid bond totalling CHF 225 mln RE
01-12 SciNeuro, Novartis sign $1.7 billion licensing deal to develop Alzheimer's drugs RE
01-12 BC Ferries Taps ABB to Equip Four New Passenger, Car Ferries MT
01-12 BNP Paribas Downgrades Swiss Life to Underperform, Lifts PT MT
01-12 UBS Group Rejects Switzerland's Proposed Disproportionate' Changes to Capital Rules MT
01-12 UBS Group Urges Switzerland to Reassess Alternatives to Capital Plan DJ
01-12 UBS Group AG rejects proposed full deduction of foreign subsidiaries from common equity tier 1 (CET1) RE
01-12 UBS rejects proposed Swiss rules, calls for less costly alternatives RE
01-12 RBC Cuts Holcim Financial Projections on Currency Exchange, Weather Trends; Price Target Down MT
01-12 Swiss stocks - Factors to watch on January 12 RE
01-12 Berenberg Expects 'Solid Trading Outlook' for Holcim in FY26; Price Target Up MT
01-09 Novartis to Develop New US Radioligand Therapy Manufacturing Site in Florida MT
01-09 Novartis to Build RLT Manufacturing Facility in Florida MT
01-09 Novartis to Build Radioligand Therapy Facility in Florida DJ
01-09 Aritzia Offering Compelling Growth Story, UBS Says MT
01-09 Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida RE
01-09 Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment DJ
01-09 Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment DJ
01-08 Medilink says it has signed an additional exclusive licensing agreement with Roche RE
01-08 Nestlé recalls some baby formula in Ethiopia, regulatory body warns consumers RE
01-08 American Homes 4 Rent shares slip 1.5% after Mizuho downgrade, UBS PT cut RE
No results for this search
See all
Detailed heatmap